Tilray Brands, Inc. (TLRY)

Market Cap	1.51B
Revenue (ttm)	743.25M
Net Income (ttm)	-351.95M
Shares Out	825.84M
EPS (ttm)	-0.44
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,524,568
Open	1.800
Previous Close	1.780
Day's Range	1.780 - 1.840
52-Week Range	1.600 - 3.400
Beta	2.20
Analysts	Hold
Price Target	2.25 (+22.95%)
Earnings Date	Jul 29, 2024

About TLRY

Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-ba...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Jul 19, 2018
• Employees: 1,600
• Stock Exchange: NASDAQ
• Ticker Symbol: TLRY

Financial Performance

In 2023, Tilray Brands's revenue was $627.12 million, a decrease of -0.20% compared to the previous year's $628.37 million. Losses were -$1.45 billion, 204.7% more than in 2022.

Analyst Forecast

According to 3 analysts, the average rating for TLRY stock is "Hold." The 12-month stock price forecast is $2.25, which is an increase of 22.95% from the latest price.

Price Target

$2.25

(22.95% upside)

Analyst Consensus: Hold